Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1376 (LINC01376) encodes a long intergenic non-coding RNA, classified as a lincRNA. These non-coding RNAs are generally more than 200 nucleotides in length, do not overlap protein-coding regions, and regulate gene expression through diverse mechanisms, including chromatin remodeling, RNA stabilization, and transcriptional modulation. While a variety of lincRNAs have been linked to tissue-specific gene regulation and disease processes, there is no published literature specifically characterizing the biological function, disease relevance, or therapeutic targeting of LINC01376. Therefore, LINC01376 is not currently considered a drug target or biomarker, nor are there known drugs interacting with it[3][5]. lincRNAs as a class fine-tune gene expression and can act in cis (locally) or trans (distantly) to affect chromatin and transcription, but the vast majority, including LINC01376, remain functionally uncharacterized[3]. If further information about LINC01376 emerges in future studies, these entries may be expanded to reflect specific molecular, cellular, or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1376 (LINC01376).